Delivery Order SPE2DR25D9112-SPE2DR26FDER1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,518.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The contract, issued on January 23, 2026, with an ultimate completion date of February 13, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating that DMS Pharmaceutical Group competed against other vendors in an...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The contract, awarded on December 17, 2025, with an ultimate completion date of January 9, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $26,855.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The contract was awarded on March 11, 2025, with an ultimate completion date of March 12, 2025, and utilized firm fixed-price pricing with no set-aside designation. This delivery order was issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The award was issued on January 28, 2026, with an ultimate completion date of February 19, 2026, under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The contract, designated as a firm fixed-price delivery order with an ultimate completion date of February 18, 2026, was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical supply requirement supporting Department of Defense medical operations. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The award, issued on January 7, 2026, with an ultimate completion date of January 29, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor's ability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The delivery order, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, was awarded on a firm fixed-price basis without set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a $15,108.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The delivery order, issued on January 14, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This award...
- SPE2DR25D9112Indefinite Delivery Contract
- SPE2DR25D9112-SPE2DR26FDER1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,518.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The contract was awarded on February 2, 2026, with an ultimate completion date of February 24, 2026, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy that authorizes the company to supply a broad range of pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare operations worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting capability as a critical supplier within the military pharmaceutical supply chain, with its parent IDC containing a $499.999 billion ceiling value and extending through December 31, 2036. The company's established performance across numerous delivery orders spanning diverse therapeutic categories—including oncology treatments, vaccines, immunosuppressants, emergency medications, and routine pharmaceuticals—positions it as a key regional prime vendor contractor under the PPV-G GEN V program. The company holds SAM registration dating to July 2001 and maintains no identified subcontractor relationships in its award documentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 2/1/26 |